Company data
Amylyx Pharmaceuticals, Inc. employees and revenue per employee
AMLX · Biotechnology · $3.35B market cap
Amylyx Pharmaceuticals, Inc. had 123 employees at the end of fiscal Dec 2024, down 68.0% from a year earlier. Revenue for the year was $87.4M, down 77.1% from a year earlier, or $710K per employee. Revenue fell, and headcount fell or held flat with it.
Employees
123
-68.0% YoY
Revenue
$87.4M
-77.1% YoY
Revenue / employee
$710K
Peer median $457K
Rank in industry
42 of 110
Biotechnology
Open roles
49
398 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2024 | 123 | $87.4M | $710K | -68.0% | -77.1% |
| Dec 2023 | 384 | $381M | $992K | +46.6% | +1612.9% |
| Dec 2022 | 262 | $22.2M | $85K | — | — |
Open roles on its job board: 49 (398 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.
Amylyx Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| ZVRA Zevra Therapeutics, Inc. | 61 | $106M | $1.75M | Efficient growth |
| ASMB Assembly Biosciences, Inc. | 73 | $72.3M | $990K | Leaner |
| AMLX Amylyx Pharmaceuticals, Inc. | 123 | $87.4M | $710K | Contracting |
| FDMT 4D Molecular Therapeutics, Inc. | 196 | $85.2M | $435K | Leaner |
| ZYME Zymeworks Inc. | 264 | $106M | $401K | Leaner |
| VRDN Viridian Therapeutics, Inc. | 252 | $70.8M | $281K | Efficient growth |
| NRIX Nurix Therapeutics, Inc. | 317 | $84.0M | $265K | Efficient growth |
| MGTX MeiraGTx Holdings plc | 400 | $81.4M | $203K | Efficient growth |
| CYTK Cytokinetics, Incorporated | 673 | $88.0M | $131K | Efficient growth |
Questions about Amylyx Pharmaceuticals, Inc.
- How many employees does Amylyx Pharmaceuticals, Inc. have?
- Amylyx Pharmaceuticals, Inc. reported 123 employees for the fiscal year ending Dec 2024, in the annual report it filed on March 4, 2025. That is down 68.0% from a year earlier.
- What is Amylyx Pharmaceuticals, Inc.'s revenue per employee?
- Amylyx Pharmaceuticals, Inc. brought in $87.4M of revenue in fiscal Dec 2024, which is $710K per employee. That ranks 42 of 110 companies we track in Biotechnology, where the median is $457K.
- Is Amylyx Pharmaceuticals, Inc. hiring?
- Amylyx Pharmaceuticals, Inc.'s public job board listed 49 open roles on November 20, 2026, about 398 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare AMLX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Amylyx Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed March 4, 2025. This is data, not a recommendation to buy or sell AMLX.